Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

ViiV Healthcare will present new data from its long-acting and [...]

Alto Neuroscience has completed patient enrollment in its Phase 2 [...]

Boehringer Ingelheim has reported Phase 2 clinical trial results showing [...]

Scancell Holdings has announced that the U.S. Food and Drug [...]

CORXEL has completed a Series D1 financing of up to [...]

Exciva GmbH has raised €51 million ($59m) in a Series [...]

Amorphical has announced positive final long-term results from its Phase [...]

  AC Immune SA has reported positive interim results from [...]

Kairos Pharma, Ltd. will present positive safety and early efficacy [...]